查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1404790

次世代定序服務市場規模、佔有率和趨勢分析報告：按服務類型、工作流程、最終用途、地區和細分市場趨勢：2024-2030

Next-generation Sequencing Services Market Size, Share & Trends Analysis Report By Service Type (Human Genome Sequencing, Gene Regulation Services), By Workflow, By End-use, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

次世代定序服務市場成長與趨勢：

Grand View Research, Inc. 的最新報告顯示，到 2030 年，全球次世代定序服務市場規模預計將達到 244.8 億美元。

預計2024年至2030年複合年成長率為22.68%。次世代定序（NGS）技術的發展在重現性和降低成本方面徹底改變了基因定序。因此，NGS 技術的一些進步已被引入，以促進其在臨床實驗室和醫院中的使用。目前該領域的大多數創新都圍繞著簡化 seq 技術並使其使用更加複雜。這些因素正在推動眾多最終用戶採用 NGS 服務。

在過去的五年裡，次世代定序儀已經從研究進展到臨床應用。大約14個國家已經啟動了大規模基因定序計劃，預計到2025年將有約6,000萬人的基因組被分析。由於基於 SEQ 的基因檢測的成長趨勢，傳統疾病檢測服務供應商正在擴大其產品組合。例如，ARUP實驗室於2022年3月宣布推出新冠狀病毒檢測，IDbyDNA, Inc.與另一家公司合作推出新冠狀病毒檢測、針對呼吸道疾病和其他呼吸道疾病的NGS檢測。

製藥和生物技術行業高通量測序的不斷成長趨勢要求開發高通量測序平台，以提高速度和便利性並簡化工作流程。因此，該公司正在專注於開發簡化樣品擴增、精製和啟動輸入的解決方案。 2022 年 3 月，Illumina 宣布發布 TruSigh Oncology (TSO) 綜合版（EU）。它是一種綜合診斷，可評估多個腫瘤基因和指標，以確定患者的個別癌症分子譜。此體外診斷（IVD）套件將有助於影響整個歐洲癌症患者的基因組測定，並將首先在歐洲進行全球首次亮相。

次世代定序服務市場報告亮點

  • 按服務類型分類，由於全基因組和全EXOME定序的日益普及，人類基因組定序在 2023 年佔據了最大的銷售佔有率。
  • 基因調控服務，尤其是小 RNA 定序和 ChIP-seq，預計在預測期內將以良好的速度成長。對 RNA 定序的投資不斷增加正在推動基因調控服務的成長。
  • 與其他工作流程步驟相比，定序服務的收益佔有率較大可能是由於安裝的定序平台數量不斷增加。這一步驟的高昂維護和恢復成本也帶來了更高的收益。
  • 按最終用途分類，由於NGS技術在癌症預後和診斷中的應用不斷擴大，以及學術機構和大學推出重大計劃，大學和其他研究機構細分市場將在2023年成長，佔收益佔有率。
  • 由於該地區技術普及高，並且有足夠的資金來採用該技術並獲得針對疾病的研究成果，北美在 2023 年佔據了市場主導地位。
  • GENEWIZ 和 Novogene 等公司基於主要 NGS 開發商的平台提供 NGS 服務。同時，Illumina、BGI等公司開發定序設備並向研究機構提供服務。
  • 2021年11月，Novogene在日本舉行的第44屆日本分子生物學會（MSBJ）年會上表示，將專門針對日本客戶推出單細胞定序服務。
  • GENEWIZ 科學家正在幫助確定計劃的 NGS 解決方案。 NeXT Dx 測試由 Personalis, Inc. 推出，旨在幫助腫瘤學家為癌症患者確定新的治療方法和臨床試驗選擇。

目錄

第1章調查方法和範圍

第 2 章執行摘要

第3章市場變數、趨勢和範圍

  • 市場體系展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場趨勢及展望
  • 市場動態
    • 價格連續下跌
    • 對婦女和生殖健康的認知不斷提高
    • 臨床NGS實施所採取的策略
  • 市場抑制因素分析
    • 實施大規模 NGS 分析工作流程的挑戰
    • 單細胞定序的分析挑戰
  • 營商環境分析
    • PESTEL分析
    • 波特五力分析
    • COVID-19感染疾病的影響分析

第4章 服務類型業務分析

  • 全球次世代定序服務市場：服務類型變化分析
  • 人類基因組解碼服務
  • 單細胞定序服務
  • 基於微生物基因組的定序服務
  • 基因控制服務
    • 小RNA測序服務
    • 晶片測序服務
    • 其他基於基因調控的服務
  • 動植物定序服務
  • 其他定序服務

第5章 工作流程業務分析

  • 全球次世代定序服務市場：工作流程變化分析
  • 預測序服務
  • 序列服務
  • 資料分析服務

第6章 最終用途業務分析

  • 全球次世代定序服務市場：最終用途變異分析
  • 大學及其他研究機構
  • 醫院和診所
  • 製藥和生物技術公司
  • 其他

第7章 區域業務分析

  • 2022年及2030年全球次世代定序服務市場佔有率（按地區）
  • 北美洲
    • 北美次世代定序服務市場，2018-2030
    • 美國
    • 加拿大
  • 歐洲
    • 歐洲次世代定序服務市場，2018-2030
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
    • 瑞士
  • 亞太地區
    • 亞太地區次世代定序服務市場，2018-2030
    • 日本
    • 中國
    • 印度
    • 韓國
    • 澳洲
    • 泰國
    • 新加坡
  • 拉丁美洲
    • 拉丁美洲次世代定序服務市場，2018-2030
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東/非洲
    • MEA次世代定序服務市場，2018-2030
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第8章競爭形勢

  • 公司分類
  • 策略規劃
  • 2023 年企業市場/定位佔有率分析
  • 公司簡介/名單
    • Quest Diagnostics Incorporated
    • ARUP Laboratories
    • Applied Biological Materials, Inc.（abm）
    • Novogene Co, Ltd.
    • Azenta Life Sciences（GENEWIZ）
    • NanoString
    • Illumina, Inc.
    • PacBio
    • Veritas
    • BGI（Beijing Genomics Institute）
    • Gene by Gene Ltd.
    • Lucigen Corporation
Product Code: GVR-2-68038-630-1

Next-generation Sequencing Services Market Growth & Trends:

The global next-generation sequencing services market size is expected to reach USD 24.48 billion by 2030, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 22.68% from 2024 to 2030. The development of next-generation sequencing (NGS) technologies has revolutionized gene sequencing in terms of reproducibility and cost savings. This has resulted in the introduction of several advancements in NGS technology to promote its usage in clinical labs and hospitals. Most current innovations in this field revolve around simplifying the usage of seq-technology and making it more sophisticated. These factors have driven the uptake of NGS services across various end-users.

Next-generation sequencing has progressed from research to clinical use in the last five years. Around 14 nations have launched large-scale genome sequencing programs, with nearly 60 million people expected to have their genome analyzed by 2025. Conventional disease testing service providers have broadened their portfolio with a rising trend of seq-based genetic tests. For instance, ARUP Laboratories announced the release of new coronavirus tests in March 2022, and IDbyDNA, Inc. partnered with another firm to introduce new coronavirus tests, an NGS test for respiratory illnesses, to aid physicians in evaluating patients with pneumonia and some other respiratory problems.

With the rising trend of high throughput sequencing within the pharma and biotech industry, there is a need for more developments to improve the speed and convenience of high throughput seq-platforms and simplify workflows. As a result, companies are focusing on the development of solutions to simplify the amplification and purification of samples and starting input. In March 2022, Illumina, Inc. announced the release of TruSigh Oncology (TSO) Comprehensive (EU), a comprehensive diagnostic that evaluates several tumor genes and indicators to identify a patient's cancer's individual molecular profile. The in vitro diagnostic (IVD) kit would assist in influencing genomic decisions for patients with cancer across Europe, with its global debut taking place first in Europe.

Next-generation Sequencing Services Market Report Highlights:

  • By service type, human genome sequencing held the largest revenue share in 2023 owing to greater penetration of whole genome and whole exome sequencing
  • Gene regulation services, particularly small RNA sequencing and ChIP-seq, are anticipated to grow at a lucrative pace during the forecast period. Rising investment in RNA sequencing is fueling the growth of gene regulation services
  • The larger revenue share of sequencing services as compared to other workflow steps can be attributed to an increase in the installation of sequencing platforms. High maintenance and recovery costs of this step have also resulted in greater revenue generation
  • By end-use, the universities and other research entities segment held the largest revenue share in 2023 owing to the growing application of NGS technology for cancer prognosis as well as diagnosis and major projects taken up by academicians and universities
  • North America dominated the market in 2023 owing to higher penetration of the technology in this region and the availability of funds to employ the technique and derive research findings for disease targeting
  • Companies such as GENEWIZ and Novogene Corporation are engaged in offering NGS services based on platforms from major NGS developers. Companies such as Illumina and BGI, on the other hand, are involved in developing sequencing instruments and offering services to research entities
  • In November 2021, Novogene stated during the 44th Annual Gathering of Molecular Biological Society of Japan (MSBJ) in Japan that they will be launching single-cell sequencing services specifically for their Japanese customers
  • GENEWIZ scientists are assisting in identifying the NGS solution for the projects. The NeXT Dx Test was launched by Personalis, Inc. to assist oncologists in identifying new therapy and clinical trial choices for cancer patients

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
    • 1.2.1. Information analysis
    • 1.2.2. Market formulation & data visualization
    • 1.2.3. Data validation & publishing
  • 1.3. Information Procurement
    • 1.3.1. Primary Others
  • 1.4. Information or Data Analysis
  • 1.5. Market Formulation & Validation
  • 1.6. Market Model
  • 1.7. Objectives
    • 1.7.1. Objective 1
    • 1.7.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Trends and Outlook
  • 3.3. Market Dynamics
    • 3.3.1. Decline in sequencing prices
    • 3.3.2. Growing awareness pertaining to women & reproductive health
    • 3.3.3. Strategies undertaken for implementation of clinical NGS
  • 3.4. Market Restraint Analysis
    • 3.4.1. Challenges pertaining to implementation of large-scale NGS analysis workflows
    • 3.4.2. Analytical challenges in single cell sequencing
  • 3.5. Business Environment Analysis
    • 3.5.1. PESTEL Analysis
    • 3.5.2. Porter's Five Forces Analysis
    • 3.5.3. COVID-19 Impact Analysis

Chapter 4. Service Type Business Analysis

  • 4.1. Global Next Generation Sequencing Services Market: Service Type Movement Analysis
  • 4.2. Human Genome Sequencing Services
    • 4.2.1. Human Genome Sequencing Services Market, 2018 - 2030 (USD Million)
  • 4.3. Single-Cell Sequencing Services
    • 4.3.1. Single-Cell Sequencing Services Market, 2018 - 2030 (USD Million)
  • 4.4. Microbial Genome-based Sequencing Services
    • 4.4.1. Microbial Genome-based Sequencing Services Market, 2018 - 2030 (USD Million)
  • 4.5. Gene Regulation Services
    • 4.5.1. Gene Regulation Services Market, 2018 - 2030 (USD Million)
    • 4.5.2. Small RNA Sequencing Services
      • 4.5.2.1. Small RNA Sequencing Services Market, 2018 - 2030 (USD Million)
    • 4.5.3. Chip Sequencing Services
      • 4.5.3.1. Chip Sequencing Services Market, 2018 - 2030 (USD Million)
    • 4.5.4. Other Gene Regulation-based Service
      • 4.5.4.1. Other Gene Regulation-based Service Market, 2018 - 2030 (USD Million)
  • 4.6. Animal & Plant Sequencing Services
    • 4.6.1. Animal & Plant Sequencing Services Market, 2018 - 2030 (USD Million)
  • 4.7. Other Sequencing Services
    • 4.7.1. Other Sequencing Services Market, 2018 - 2030 (USD Million)

Chapter 5. Workflow Business Analysis

  • 5.1. Global Next Generation Sequencing Services market: Workflow Movement Analysis
  • 5.2. Pre Sequencing Service
    • 5.2.1. Pre Sequencing Service Market, 2018 - 2030 (USD Million)
  • 5.3. Sequencing Service
    • 5.3.1. Sequencing Service Market, 2018 - 2030 (USD Million)
  • 5.4. Data Analysis Service
    • 5.4.1. Data Analysis Service Market, 2018 - 2030 (USD Million)

Chapter 6. End-use Business Analysis

  • 6.1. Global Next Generation Sequencing Services Market: End-use Movement Analysis
  • 6.2. Universities & Other Research Entities
    • 6.2.1. Universities & Other Research Entities Market, 2018 - 2030 (USD Million)
  • 6.3. Hospitals & Clinics
    • 6.3.1. Hospitals & Clinics Market, 2018 - 2030 (USD Million)
  • 6.4. Pharma & Biotech Entities
    • 6.4.1. Pharma & Biotech Entities Market, 2018 - 2030 (USD Million)
  • 6.5. Others
    • 6.5.1. Others Market, 2018 - 2030 (USD Million)

Chapter 7. Regional Business Analysis

  • 7.1. Global Next generation sequencing services market Share By Region, 2022 & 2030
  • 7.2. North America
    • 7.2.1. North America Next generation sequencing services market, 2018 - 2030 (USD Million)
    • 7.2.2. U.S.
      • 7.2.2.1. Key Country Dynamics
      • 7.2.2.2. Competitive Scenario
      • 7.2.2.3. Regulatory Framework
      • 7.2.2.4. Target Disease Prevalence
      • 7.2.2.5. U.S. Next generation sequencing services market, 2018 - 2030 (USD Million)
    • 7.2.3. Canada
      • 7.2.3.1. Key Country Dynamics
      • 7.2.3.2. Competitive Scenario
      • 7.2.3.3. Regulatory Framework
      • 7.2.3.4. Target Disease Prevalence
      • 7.2.3.5. Canada Next generation sequencing services market, 2018 - 2030 (USD Million)
  • 7.3. Europe
    • 7.3.1. Europe Next generation sequencing services market, 2018 - 2030 (USD Million)
    • 7.3.2. Germany
      • 7.3.2.1. Key Country Dynamics
      • 7.3.2.2. Competitive Scenario
      • 7.3.2.3. Regulatory Framework
      • 7.3.2.4. Target Disease Prevalence
      • 7.3.2.5. Germany Next generation sequencing services market, 2018 - 2030 (USD Million)
    • 7.3.3. UK
      • 7.3.3.1. Key Country Dynamics
      • 7.3.3.2. Competitive Scenario
      • 7.3.3.3. Regulatory Framework
      • 7.3.3.4. Target Disease Prevalence
      • 7.3.3.5. UK Next generation sequencing services market, 2018 - 2030 (USD Million)
    • 7.3.4. France
      • 7.3.4.1. Key Country Dynamics
      • 7.3.4.2. Competitive Scenario
      • 7.3.4.3. Regulatory Framework
      • 7.3.4.4. Target Disease Prevalence
      • 7.3.4.5. France Next generation sequencing services market, 2018 - 2030 (USD Million)
    • 7.3.5. Italy
      • 7.3.5.1. Key Country Dynamics
      • 7.3.5.2. Competitive Scenario
      • 7.3.5.3. Regulatory Framework
      • 7.3.5.4. Target Disease Prevalence
      • 7.3.5.5. Italy Next generation sequencing services market, 2018 - 2030 (USD Million)
    • 7.3.6. Spain
      • 7.3.6.1. Key Country Dynamics
      • 7.3.6.2. Competitive Scenario
      • 7.3.6.3. Regulatory Framework
      • 7.3.6.4. Target Disease Prevalence
      • 7.3.6.5. Spain Next generation sequencing services market, 2018 - 2030 (USD Million)
    • 7.3.7. Denmark
      • 7.3.7.1. Key Country Dynamics
      • 7.3.7.2. Competitive Scenario
      • 7.3.7.3. Regulatory Framework
      • 7.3.7.4. Target Disease Prevalence
      • 7.3.7.5. Denmark Next generation sequencing services market, 2018 - 2030 (USD Million)
    • 7.3.8. Sweden
      • 7.3.8.1. Key Country Dynamics
      • 7.3.8.2. Competitive Scenario
      • 7.3.8.3. Regulatory Framework
      • 7.3.8.4. Target Disease Prevalence
      • 7.3.8.5. Sweden Next generation sequencing services market, 2018 - 2030 (USD Million)
    • 7.3.9. Norway
      • 7.3.9.1. Key Country Dynamics
      • 7.3.9.2. Competitive Scenario
      • 7.3.9.3. Regulatory Framework
      • 7.3.9.4. Target Disease Prevalence
      • 7.3.9.5. Norway Next generation sequencing services market, 2018 - 2030 (USD Million)
    • 7.3.10. Switzerland
      • 7.3.10.1. Key Country Dynamics
      • 7.3.10.2. Competitive Scenario
      • 7.3.10.3. Regulatory Framework
      • 7.3.10.4. Target Disease Prevalence
      • 7.3.10.5. Switzerland Next generation sequencing services market, 2018 - 2030 (USD Million)
  • 7.4. Asia Pacific
    • 7.4.1. Asia Pacific Next generation sequencing services market, 2018 - 2030 (USD Million)
    • 7.4.2. Japan
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Competitive Scenario
      • 7.4.2.3. Regulatory Framework
      • 7.4.2.4. Target Disease Prevalence
      • 7.4.2.5. Japan Next generation sequencing services market, 2018 - 2030 (USD Million)
    • 7.4.3. China
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Competitive Scenario
      • 7.4.3.3. Regulatory Framework
      • 7.4.3.4. Target Disease Prevalence
      • 7.4.3.5. China Next generation sequencing services market, 2018 - 2030 (USD Million)
    • 7.4.4. India
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Competitive Scenario
      • 7.4.4.3. Regulatory Framework
      • 7.4.4.4. Target Disease Prevalence
      • 7.4.4.5. India Next generation sequencing services market, 2018 - 2030 (USD Million)
    • 7.4.5. South Korea
      • 7.4.5.1. Key Country Dynamics
      • 7.4.5.2. Competitive Scenario
      • 7.4.5.3. Regulatory Framework
      • 7.4.5.4. Target Disease Prevalence
      • 7.4.5.5. South Korea Next generation sequencing services market, 2018 - 2030 (USD Million)
    • 7.4.6. Australia
      • 7.4.6.1. Key Country Dynamics
      • 7.4.6.2. Competitive Scenario
      • 7.4.6.3. Regulatory Framework
      • 7.4.6.4. Target Disease Prevalence
      • 7.4.6.5. Australia Next generation sequencing services market, 2018 - 2030 (USD Million)
    • 7.4.7. Thailand
      • 7.4.7.1. Key Country Dynamics
      • 7.4.7.2. Competitive Scenario
      • 7.4.7.3. Regulatory Framework
      • 7.4.7.4. Target Disease Prevalence
      • 7.4.7.5. Thailand Next generation sequencing services market, 2018 - 2030 (USD Million)
    • 7.4.8. Singapore
      • 7.4.8.1. Key Country Dynamics
      • 7.4.8.2. Competitive Scenario
      • 7.4.8.3. Regulatory Framework
      • 7.4.8.4. Target Disease Prevalence
      • 7.4.8.5. Singapore Next generation sequencing services market, 2018 - 2030 (USD Million)
  • 7.5. Latin America
    • 7.5.1. Latin America Next generation sequencing services market, 2018 - 2030 (USD Million)
    • 7.5.2. Brazil
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Competitive Scenario
      • 7.5.2.3. Regulatory Framework
      • 7.5.2.4. Target Disease Prevalence
      • 7.5.2.5. Brazil Next generation sequencing services market, 2018 - 2030 (USD Million)
    • 7.5.3. Mexico
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Competitive Scenario
      • 7.5.3.3. Regulatory Framework
      • 7.5.3.4. Target Disease Prevalence
      • 7.5.3.5. Mexico Next generation sequencing services market, 2018 - 2030 (USD Million)
    • 7.5.4. Argentina
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Competitive Scenario
      • 7.5.4.3. Regulatory Framework
      • 7.5.4.4. Target Disease Prevalence
      • 7.5.4.5. Argentina Next generation sequencing services market, 2018 - 2030 (USD Million)
  • 7.6. MEA
    • 7.6.1. MEA Next generation sequencing services market, 2018 - 2030 (USD Million)
    • 7.6.2. South Africa
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Competitive Scenario
      • 7.6.2.3. Regulatory Framework
      • 7.6.2.4. Target Disease Prevalence
      • 7.6.2.5. South Africa Next generation sequencing services market, 2018 - 2030 (USD Million)
    • 7.6.3. Saudi Arabia
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Competitive Scenario
      • 7.6.3.3. Regulatory Framework
      • 7.6.3.4. Target Disease Prevalence
      • 7.6.3.5. Saudi Arabia Next generation sequencing services market, 2018 - 2030 (USD Million)
    • 7.6.4. UAE
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Competitive Scenario
      • 7.6.4.3. Regulatory Framework
      • 7.6.4.4. Target Disease Prevalence
      • 7.6.4.5. UAE Next generation sequencing services market, 2018 - 2030 (USD Million)
    • 7.6.5. Kuwait
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Competitive Scenario
      • 7.6.5.3. Regulatory Framework
      • 7.6.5.4. Target Disease Prevalence
      • 7.6.5.5. Kuwait Next generation sequencing services market, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Company Categorization
  • 8.2. Strategy Mapping
  • 8.3. Company Market/Position Share Analysis, 2023
  • 8.4. Company Profiles/Listing
    • 8.4.1. Quest Diagnostics Incorporated
      • 8.4.1.1. Overview
      • 8.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.1.3. Product Benchmarking
      • 8.4.1.4. Strategic Initiatives
    • 8.4.2. ARUP Laboratories
      • 8.4.2.1. Overview
      • 8.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.2.3. Product Benchmarking
      • 8.4.2.4. Strategic Initiatives
    • 8.4.3. Applied Biological Materials, Inc. (abm)
      • 8.4.3.1. Overview
      • 8.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.3.3. Product Benchmarking
      • 8.4.3.4. Strategic Initiatives
    • 8.4.4. Novogene Co, Ltd.
      • 8.4.4.1. Overview
      • 8.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.4.3. Product Benchmarking
      • 8.4.4.4. Strategic Initiatives
    • 8.4.5. Azenta Life Sciences (GENEWIZ)
      • 8.4.5.1. Overview
      • 8.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.5.3. Product Benchmarking
      • 8.4.5.4. Strategic Initiatives
    • 8.4.6. NanoString
      • 8.4.6.1. Overview
      • 8.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.6.3. Product Benchmarking
      • 8.4.6.4. Strategic Initiatives
    • 8.4.7. Illumina, Inc.
      • 8.4.7.1. Overview
      • 8.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.7.3. Product Benchmarking
      • 8.4.7.4. Strategic Initiatives
    • 8.4.8. PacBio
      • 8.4.8.1. Overview
      • 8.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.8.3. Product Benchmarking
      • 8.4.8.4. Strategic Initiatives
    • 8.4.9. Veritas
      • 8.4.9.1. Overview
      • 8.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.9.3. Product Benchmarking
      • 8.4.9.4. Strategic Initiatives
    • 8.4.10. BGI (Beijing Genomics Institute)
      • 8.4.10.1. Overview
      • 8.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.10.3. Product Benchmarking
      • 8.4.10.4. Strategic Initiatives
    • 8.4.11. Gene by Gene Ltd.
      • 8.4.11.1. Overview
      • 8.4.11.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.11.3. Product Benchmarking
      • 8.4.11.4. Strategic Initiatives
    • 8.4.12. Lucigen Corporation
      • 8.4.12.1. Overview
      • 8.4.12.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.12.3. Product Benchmarking
      • 8.4.12.4. Strategic Initiatives

List of Tables

  • Table 1 List Of Secondary Sources
  • Table 2 List Of Abbreviations
  • Table 3 Global next generation sequencing services market by service type, 2018 - 2030 (USD Million)
  • Table 4 Global next generation sequencing services market by workflow, 2018 - 2030 (USD Million)
  • Table 5 Global next generation sequencing services market by end-use, 2018 - 2030 (USD Million)
  • Table 6 North America next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
  • Table 7 North America next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 8 North America next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 9 North America next-generation sequencing services market estimates & forecasts, by country, 2018 - 2030 (USD Million)
  • Table 10 U.S. next-generation sequencing services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
  • Table 11 U.S. next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 12 U.S. next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 13 Canada next-generation sequencing services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
  • Table 14 Canada next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 15 Canada next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 16 Europe next-generation sequencing services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
  • Table 17 Europe next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 18 Europe next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 19 Europe next-generation sequencing services market estimates & forecasts, by country, 2018 - 2030 (USD Million)
  • Table 20 Germany next-generation sequencing services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
  • Table 21 Germany next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 22 Germany next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 23 UK next-generation sequencing services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
  • Table 24 UK next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 25 UK next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 26 France next-generation sequencing services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
  • Table 27 France next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 28 France next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 29 Italy next-generation sequencing services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
  • Table 30 Italy next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 31 Italy next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 32 Spain next-generation sequencing services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
  • Table 33 Spain next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 34 Spain next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 35 Denmark next-generation sequencing services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
  • Table 36 Denmark next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 37 Denmark next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 38 Sweden next-generation sequencing services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
  • Table 39 Sweden next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 40 Sweden next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 41 Norway next-generation sequencing services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
  • Table 42 Norway next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 43 Norway next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 44 Switzerland next-generation sequencing services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
  • Table 45 Switzerland next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 46 Switzerland next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 47 Asia Pacific next-generation sequencing services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
  • Table 48 Asia Pacific next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 49 Asia Pacific next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 50 Asia Pacific next-generation sequencing services market estimates & forecasts, by country, 2018 - 2030 (USD Million)
  • Table 51 Japan next-generation sequencing services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
  • Table 52 Japan next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 53 Japan next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 54 China next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
  • Table 55 China next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 56 China next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 57 India next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
  • Table 58 India next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 59 India next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 60 Australia next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
  • Table 61 Australia next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 62 Australia next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 63 South Korea next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
  • Table 64 South Korea next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 65 South Korea next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 66 Thailand next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
  • Table 67 Thailand next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 68 Thailand next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 69 Singapore next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
  • Table 70 Singapore next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 71 Singapore next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 72 Latin America next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
  • Table 73 Latin America next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 74 Latin America next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 75 Latin America next-generation sequencing services market estimates & forecasts, by country, 2018 - 2030 (USD Million)
  • Table 76 Brazil next-generation sequencing services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
  • Table 77 Brazil next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 78 Brazil next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 79 Mexico next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
  • Table 80 Mexico next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 81 Mexico next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 82 Argentina next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
  • Table 83 Argentina next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 84 Argentina next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 85 MEA next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
  • Table 86 MEA next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 87 MEA next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 88 MEA next-generation sequencing services market estimates & forecasts, by country, 2018 - 2030 (USD Million)
  • Table 89 South Africa next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
  • Table 90 South Africa next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 91 South Africa next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 92 Saudi Arabia next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
  • Table 93 Saudi Arabia next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 94 Saudi Arabia next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 95 UAE next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
  • Table 96 UAE next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 97 UAE next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 98 Kuwait next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
  • Table 99 Kuwait next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 100 Kuwait next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 101 Participant's Overview
  • Table 102 Financial Performance
  • Table 103 Key Companies Undergoing Expansions
  • Table 104 Key Companies Undergoing Acquisitions
  • Table 105 Key Companies Undergoing Collaborations
  • Table 106 Key Companies Launching New Products/Services
  • Table 107 Key Companies Undergoing Partnerships
  • Table 108 Key Companies Undertaking Other Strategies

List of Figures

  • Fig. 1 Market Others process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary Others pattern
  • Fig. 4 Market Others approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Market summary, 2023 (USD Million)
  • Fig. 9 Market segmentation & scope
  • Fig. 10 Market driver impact
  • Fig. 11 Market restraint impact
  • Fig. 12 Penetration & growth prospect mapping
  • Fig. 13 Porter's analysis
  • Fig. 14 SWOT analysis
  • Fig. 15 Next-generation sequencing services market: Service type outlook and key takeaways
  • Fig. 16 Next-generation sequencing services market: Service type movement analysis
  • Fig. 17 Human genome sequencing services market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 18 Single-cell sequencing services market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 19 Microbial genome-based sequencing services market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 20 Gene regulation services market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 21 Small RNA sequencing services market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 22 Chip sequencing service market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 23 Other gene regulation-based service market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 24 Animal & plant sequencing services market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 25 Other sequencing services market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 26 Next-generation sequencing services market: Workflow outlook and key takeaways
  • Fig. 27 Next generation sequencing services market: Workflow movement analysis
  • Fig. 28 Pre sequencing services market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 29 Sequencing services market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 30 Data analysis service market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 31 Next-generation sequencing services market: End-use outlook and key takeaways
  • Fig. 32 Next-generation sequencing services market: End-use movement analysis
  • Fig. 33 Universities & other research entities, 2018 - 2030 (USD Million)
  • Fig. 34 Hospitals & clinics, 2018 - 2030 (USD Million)
  • Fig. 35 Pharma & biotech entities, 2018 - 2030 (USD Million)
  • Fig. 36 Other end-use, 2018 - 2030 (USD Million)
  • Fig. 37 Global next generation sequencing services market: Regional outlook and key takeaways
  • Fig. 38 North America next generation sequencing services market, 2018 - 2030 (USD million)
  • Fig. 39 US key country dynamics
  • Fig. 40 US next generation sequencing services market, 2018 - 2030 (USD million)
  • Fig. 41 Canada key country dynamics
  • Fig. 42 Canada next generation sequencing services market, 2018 - 2030 (USD million)
  • Fig. 43 Europe next generation sequencing services market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 44 Germany key country dynamics
  • Fig. 45 Germany next generation sequencing services market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 46 France key country dynamics
  • Fig. 47 France next generation sequencing services market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 48 UK key country dynamics
  • Fig. 49 UK next generation sequencing services market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 50 Italy key country dynamics
  • Fig. 51 Italy next generation sequencing services market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 52 Spain key country dynamics
  • Fig. 53 Spain next generation sequencing services market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 54 Denmark key country dynamics
  • Fig. 55 Denmark next generation sequencing services market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 56 Sweden key country dynamics
  • Fig. 57 Sweden next generation sequencing services market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 58 Norway key country dynamics
  • Fig. 59 Norway next generation sequencing services market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 60 Switzerland key country dynamics
  • Fig. 61 Switzerland next generation sequencing services market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 62 Asia-Pacific next generation sequencing services market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 63 China key country dynamics
  • Fig. 64 China next generation sequencing services market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 65 India key country dynamics
  • Fig. 66 India next generation sequencing services market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 67 South Korea key country dynamics
  • Fig. 68 South Korea next generation sequencing services market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 69 Japan key country dynamics
  • Fig. 70 Japan next generation sequencing services market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 71 Australia key country dynamics
  • Fig. 72 Australia next generation sequencing services market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 73 Thailand key country dynamics
  • Fig. 74 Thailand next generation sequencing services market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 75 Singapore key country dynamics
  • Fig. 76 Singopore next generation sequencing services market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 77 Latin America next generation sequencing services market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 78 Brazil key country dynamics
  • Fig. 79 Brazil next generation sequencing services market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 80 Mexico key country dynamics
  • Fig. 81 Mexico next generation sequencing services market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 82 Argentina key country dynamics
  • Fig. 83 Argentina next generation sequencing services market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 84 MEA next generation sequencing services market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 85 South Africa key country dynamics
  • Fig. 86 South Africa next generation sequencing services market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 87 Saudi Arabia key country dynamics
  • Fig. 88 Saudi Arabia next generation sequencing services market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 89 UAE key country dynamics
  • Fig. 90 UAE next generation sequencing services market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 91 Kuwait key country dynamics
  • Fig. 92 Kuwait next generation sequencing services market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 93 Market participant categorization
  • Fig. 94 Next generation sequencing services market share analysis, 2023
  • Fig. 95 Strategy framework